Human Genome Sciences, Inc. (HGSI) Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
8/28/2007 7:31:18 AM
More...
|
Human Genome Sciences, Inc. (HGSI) Announces $40 Million Milestone Payment Related to Albuferon(R) Development
8/28/2007 7:23:27 AM
More...
|
European Experts Recommended Against Approving Novartis AG's Antifungal Drug Mycograb
11/17/2006 11:36:28 AM
More...
|
ADHD Drugs To Have Stronger Warning; Include Novartis International AG (NVS)'s Dexedrine And GlaxoSmithKline Biologicals (GSK)'s Ritalin
8/22/2006 8:23:53 AM
More...
|
Novartis Pharma Obtains Additional Approval For Its Proprietary Immunosuppressant Neoral
6/16/2006 2:59:32 PM
More...
|
Formulatrix Announces Licensing Agreement
11/1/2005 3:18:44 PM
More...
|
Novartis AG (NVS) Paying US$5.1 Billion For Rest Of Shares In Chiron Corporation (CHIR)
10/31/2005 10:26:01 AM
More...
|
Novartis Pharma AG (NVS) In UK Biotech Deal Worth Up To $375 Milllon
10/19/2005 5:13:16 PM
More...
|
Novartis Pharma AG (NVS) Warns Of Skin Problems With Epilepsy Drug
10/19/2005 5:13:13 PM
More...
|
Novartis Pharma AG (NVS) Obtains Rights From Otsuka Pharmaceutical Co., Ltd. To Develop New Treatment For Dry Eye
10/19/2005 5:12:38 PM
More...
|
|